• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effect of a Change in Papillary Thyroid Cancer Terminology on Anxiety Levels and Treatment Preferences: A Randomized Crossover Trial.甲状腺癌术语变更对焦虑水平和治疗偏好的影响:一项随机交叉试验。
JAMA Otolaryngol Head Neck Surg. 2018 Oct 1;144(10):867-874. doi: 10.1001/jamaoto.2018.1272.
2
Association of Preferences for Papillary Thyroid Cancer Treatment With Disease Terminology: A Discrete Choice Experiment.甲状腺乳头癌治疗偏好与疾病术语的关联:离散选择实验。
JAMA Otolaryngol Head Neck Surg. 2018 Oct 1;144(10):887-896. doi: 10.1001/jamaoto.2018.1694.
3
Public perceptions of changing the terminology for low-risk thyroid cancer: a qualitative focus group study.公众对低危甲状腺癌术语改变的看法:一项定性焦点小组研究。
BMJ Open. 2019 Feb 5;9(2):e025820. doi: 10.1136/bmjopen-2018-025820.
4
Terminology Change for Small Low-Risk Papillary Thyroid Cancer As a Response to Overtreatment: Results from Three Australian Community Juries.小低危甲状腺乳头状癌治疗过度应对术语变更:来自澳大利亚三个社区陪审团的结果。
Thyroid. 2021 Jul;31(7):1067-1075. doi: 10.1089/thy.2020.0694. Epub 2021 Jan 5.
5
Clinicians' Views on Management and Terminology for Papillary Thyroid Microcarcinoma: A Qualitative Study.临床医生对甲状腺微小乳头状癌管理及术语的看法:一项定性研究
Thyroid. 2017 May;27(5):661-671. doi: 10.1089/thy.2016.0483. Epub 2017 Mar 21.
6
Decision Regret Following the Choice of Surgery or Active Surveillance for Small, Low-Risk Papillary Thyroid Cancer: A Prospective Cohort Study.小的低风险乳头状甲状腺癌手术或主动监测选择后的决策遗憾:一项前瞻性队列研究
Thyroid. 2024 May;34(5):626-634. doi: 10.1089/thy.2023.0634. Epub 2024 Apr 8.
7
From Overdiagnosis to Overtreatment of Low-Risk Thyroid Cancer: A Thematic Analysis of Attitudes and Beliefs of Endocrinologists, Surgeons, and Patients.从过度诊断到低危甲状腺癌的过度治疗:内分泌学家、外科医生和患者态度和信念的主题分析。
Thyroid. 2020 May;30(5):696-703. doi: 10.1089/thy.2019.0587. Epub 2020 Feb 7.
8
A Prospective Mixed-Methods Study of Decision-Making on Surgery or Active Surveillance for Low-Risk Papillary Thyroid Cancer.一项关于低危型甲状腺乳头状癌手术或主动监测决策的前瞻性混合方法研究。
Thyroid. 2020 Jul;30(7):999-1007. doi: 10.1089/thy.2019.0592. Epub 2020 Apr 8.
9
Early Diagnosis of Low-Risk Papillary Thyroid Cancer Results Rather in Overtreatment Than a Better Survival.低危型甲状腺乳头状癌的早期诊断结果往往是过度治疗而非更好的生存。
Front Endocrinol (Lausanne). 2020 Oct 6;11:571421. doi: 10.3389/fendo.2020.571421. eCollection 2020.
10
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.包膜滤泡型甲状腺乳头状癌命名法修订:减少惰性肿瘤过度治疗的范式转变。
JAMA Oncol. 2016 Aug 1;2(8):1023-9. doi: 10.1001/jamaoncol.2016.0386.

引用本文的文献

1
Cancer Labeling, Risk Perception, and Treatment Choices in Clonal Cytopenia of Undetermined Significance.意义未明的克隆性血细胞减少症中的癌症标签、风险认知及治疗选择
JAMA Netw Open. 2025 Jul 1;8(7):e2523733. doi: 10.1001/jamanetworkopen.2025.23733.
2
The Effect of a Surgeon Communication Strategy on Treatment Preference for Thyroid Cancer: A Randomized Trial.外科医生沟通策略对甲状腺癌治疗偏好的影响:一项随机试验。
Med Decis Making. 2025 May;45(4):426-436. doi: 10.1177/0272989X251325837. Epub 2025 Mar 27.
3
Effect of Changes in Canine Thyroid Cancer Terminology on Caregiver Anxiety Levels and Treatment Preferences in a Scenario-Based Study.在一项基于情景的研究中,犬甲状腺癌术语变化对护理人员焦虑水平和治疗偏好的影响。
Vet Comp Oncol. 2025 Jun;23(2):187-196. doi: 10.1111/vco.13044. Epub 2025 Feb 24.
4
Sex-modulated association between thyroid stimulating hormone and informant-perceived anxiety in non-depressed older adults: Prediction models and relevant cutoff value.非抑郁老年人中促甲状腺激素与 informant 感知焦虑之间的性别调节关联:预测模型及相关临界值
Sci Rep. 2025 Jan 20;15(1):2526. doi: 10.1038/s41598-025-86703-7.
5
Impact of alternative diagnostic labels for melanoma in situ on management choices and psychological outcomes: protocol for an online randomised study.原位黑色素瘤替代诊断标签对管理选择和心理结果的影响:一项在线随机研究方案
BMJ Open. 2024 Dec 20;14(12):e089558. doi: 10.1136/bmjopen-2024-089558.
6
A Scoping Review of Patient Health-Related Quality of Life Following Surgery or Molecular Testing for Individuals with Indeterminate Thyroid Nodules.对甲状腺结节性质不明的个体进行手术或分子检测后患者健康相关生活质量的范围综述
Healthcare (Basel). 2024 Oct 11;12(20):2025. doi: 10.3390/healthcare12202025.
7
Implementing active surveillance for low-risk thyroid carcinoma into clinical practice: collaborative recommendations for Latin America.将低危甲状腺癌的主动监测纳入临床实践:拉丁美洲的合作建议。
Arch Endocrinol Metab. 2024 Jun 3;68:e230371. doi: 10.20945/2359-4292-2023-0371. eCollection 2024.
8
The Influencing Factors of Psychosocial Adaptation of Cancer Patients: A Systematic Review and Meta-Analysis.癌症患者心理社会适应的影响因素:系统评价与Meta分析
Health Serv Insights. 2024 Sep 11;17:11786329241278814. doi: 10.1177/11786329241278814. eCollection 2024.
9
Impact of the diagnostic label for a low-risk prostate lesion: protocol for two online factorial randomised experiments.低危前列腺病变诊断标签的影响:两项在线析因随机对照实验方案。
BMJ Open. 2024 Aug 9;14(8):e085947. doi: 10.1136/bmjopen-2024-085947.
10
The impact of delayed diagnosis and treatment due to COVID-19 on Australian thyroid cancer patients: a qualitative interview study.由于 COVID-19 导致的诊断和治疗延误对澳大利亚甲状腺癌患者的影响:一项定性访谈研究。
BMJ Open. 2024 Apr 15;14(4):e069236. doi: 10.1136/bmjopen-2022-069236.

本文引用的文献

1
Active Surveillance for Low-Risk Cancers - A Viable Solution to Overtreatment?低风险癌症的主动监测——过度治疗的可行解决方案?
N Engl J Med. 2017 Jul 20;377(3):203-206. doi: 10.1056/NEJMp1703787.
2
Words do matter: a systematic review on how different terminology for the same condition influences management preferences.用词至关重要:关于同一病症的不同术语如何影响管理偏好的系统评价。
BMJ Open. 2017 Jul 10;7(7):e014129. doi: 10.1136/bmjopen-2016-014129.
3
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.1974 - 2013年美国甲状腺癌发病率和死亡率趋势
JAMA. 2017 Apr 4;317(13):1338-1348. doi: 10.1001/jama.2017.2719.
4
Clinicians' Views on Management and Terminology for Papillary Thyroid Microcarcinoma: A Qualitative Study.临床医生对甲状腺微小乳头状癌管理及术语的看法:一项定性研究
Thyroid. 2017 May;27(5):661-671. doi: 10.1089/thy.2016.0483. Epub 2017 Mar 21.
5
Experience of US Patients Who Self-identify as Having an Overdiagnosed Thyroid Cancer: A Qualitative Analysis.自我认定患有过度诊断甲状腺癌的美国患者的经历:一项定性分析。
JAMA Otolaryngol Head Neck Surg. 2017 Jul 1;143(7):663-669. doi: 10.1001/jamaoto.2016.4749.
6
Evidence for overuse of medical services around the world.世界各地医疗服务过度使用的证据。
Lancet. 2017 Jul 8;390(10090):156-168. doi: 10.1016/S0140-6736(16)32585-5. Epub 2017 Jan 9.
7
Prevalence of Differentiated Thyroid Cancer in Autopsy Studies Over Six Decades: A Meta-Analysis.六十年尸检研究中分化型甲状腺癌的患病率:一项荟萃分析。
J Clin Oncol. 2016 Oct 20;34(30):3672-3679. doi: 10.1200/JCO.2016.67.7419.
8
Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis.全球甲状腺癌流行?过度诊断的影响日益增大。
N Engl J Med. 2016 Aug 18;375(7):614-7. doi: 10.1056/NEJMp1604412.
9
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.包膜滤泡型甲状腺乳头状癌命名法修订:减少惰性肿瘤过度治疗的范式转变。
JAMA Oncol. 2016 Aug 1;2(8):1023-9. doi: 10.1001/jamaoncol.2016.0386.
10
Noninvasive Encapsulated Follicular Variant of Papillary Thyroid "Cancer" (or Not): Time for a Name Change.甲状腺乳头状“癌”(或并非如此)的非侵袭性包裹性滤泡变体:是时候改名了。
JAMA Oncol. 2016 Aug 1;2(8):1005-6. doi: 10.1001/jamaoncol.2016.0714.

甲状腺癌术语变更对焦虑水平和治疗偏好的影响:一项随机交叉试验。

Effect of a Change in Papillary Thyroid Cancer Terminology on Anxiety Levels and Treatment Preferences: A Randomized Crossover Trial.

机构信息

Wiser Healthcare, Sydney School of Public Health, The University of Sydney, Sydney, Sydney, New South Wales, Australia.

Sydney Health Literacy Lab, School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.

出版信息

JAMA Otolaryngol Head Neck Surg. 2018 Oct 1;144(10):867-874. doi: 10.1001/jamaoto.2018.1272.

DOI:10.1001/jamaoto.2018.1272
PMID:30335875
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6233823/
Abstract

IMPORTANCE

Given evidence of overdiagnosis and overtreatment of small papillary thyroid cancers (PTCs), strategies are needed to promote the consideration of less invasive treatment options for patients with low-risk PTC.

OBJECTIVE

To determine the association of treatment preferences and anxiety levels for PTC with the terminology used to describe the condition.

DESIGN, SETTING, AND PARTICIPANTS: This randomized crossover study involved a community sample of 550 Australian men and women 18 years or older without a history of thyroid cancer. Between March 16, 2016, and July 26, 2016, participants accessed an online study that presented 3 hypothetical but clinically realistic scenarios, each of which described PTC as papillary thyroid cancer, papillary lesion, or abnormal cells. Participants were exposed to all 3 scenarios with the different terminologies, and participants were randomized by the order (first, second, or third) in which they viewed the terminologies. Data analysis was conducted from September 1, 2016, to May 15, 2017.

MAIN OUTCOMES AND MEASURES

Treatment choice (total thyroidectomy, hemithyroidectomy, or active surveillance), diagnosis anxiety, and treatment choice anxiety.

RESULTS

Of the 550 participants who completed the online study and were included in the analysis, 279 (50.7%) were female and the mean (SD) age was 49.9 (15.2) years. A higher proportion of participants (108 [19.6%]) chose total thyroidectomy when papillary thyroid cancer was used to describe the condition compared with the percentage of participants who chose total thyroidectomy when papillary lesion (58 [10.5%]) or abnormal cells (60 [10.9%]) terminology was used. At first exposure, the papillary thyroid cancer terminology led 60 of 186 participants (32.3%) to choose surgery compared with 46 of 191 participants (24.1%) who chose surgery after being exposed to papillary lesion terminology first (risk ratio [RR], 0.73; 95% CI, 0.53-1.02) and 47 of 173 participants (27.2%) after being exposed to abnormal cells (RR, 0.82; 95% CI, 0.60-1.14) terminology first. After the first exposure, participants who viewed papillary thyroid cancer terminology reported significantly higher levels of anxiety (mean, 7.8 of 11 points) compared with those who viewed the papillary lesion (mean, 7.0 of 11 points; mean difference, -0.8; 95% CI, -1.3 to -0.3) or abnormal cells (mean, 7.3 of 11 points; mean difference, -0.5; 95% CI, -1.0 to 0.01). Overall, interest in active surveillance was high and higher levels of anxiety were reported by those who chose surgery, regardless of which terminology was viewed first (mean difference, 1.5; 95% CI, 1.0-1.9).

CONCLUSIONS AND RELEVANCE

Changing the terminology of small PTCs may be one strategy to reduce patients' anxiety levels and help them consider less invasive management options. To curtail overdiagnosis and overtreatment in PTC, other strategies may include providing balanced information about the risks and advantages of alternative treatments.

TRIAL REGISTRATION

anzctr.org.au Identifier: ACTRN12616000271404.

摘要

重要性

鉴于小乳头状甲状腺癌(PTC)存在过度诊断和过度治疗的证据,因此需要制定策略,以促进为低危 PTC 患者考虑采用侵袭性较小的治疗方案。

目的

确定 PTC 治疗偏好和焦虑水平与用于描述该疾病的术语之间的关联。

设计、设置和参与者:这是一项随机交叉研究,纳入了 550 名澳大利亚 18 岁及以上、无甲状腺癌病史的男性和女性社区样本。2016 年 3 月 16 日至 2016 年 7 月 26 日期间,参与者访问了一个在线研究,该研究提供了 3 种假设但临床现实的情况,每种情况均将 PTC 描述为乳头状甲状腺癌、乳头状病变或异常细胞。参与者接触了所有 3 种不同术语的情况,参与者按他们查看术语的顺序(第一、第二或第三)进行随机分组。数据分析于 2017 年 9 月 1 日至 2017 年 5 月 15 日进行。

主要结局和测量

治疗选择(甲状腺全切除术、甲状腺叶切除术或主动监测)、诊断焦虑和治疗选择焦虑。

结果

在完成在线研究并纳入分析的 550 名参与者中,279 名(50.7%)为女性,平均(SD)年龄为 49.9(15.2)岁。与使用乳头状病变术语时相比,当使用乳头状甲状腺癌术语描述病情时,选择甲状腺全切除术的参与者比例更高(108 例[19.6%]),而选择甲状腺全切除术的参与者比例为 58 例(10.5%)。首次暴露时,186 名参与者中有 60 名(32.3%)选择手术治疗,而 191 名参与者中有 46 名(24.1%)在首次接触乳头状病变术语后选择手术治疗(风险比[RR],0.73;95%CI,0.53-1.02),173 名参与者中有 47 名(27.2%)在首次接触异常细胞术语后选择手术治疗(RR,0.82;95%CI,0.60-1.14)。首次暴露后,观看乳头状甲状腺癌术语的参与者报告的焦虑水平明显高于观看乳头状病变(平均 7.8 分/11 分)或异常细胞(平均 7.3 分/11 分)术语的参与者(平均差异,-0.8;95%CI,-1.3 至 -0.3)。总的来说,对主动监测很感兴趣,无论首先观看哪种术语,选择手术治疗的参与者报告的焦虑水平更高(平均差异,1.5;95%CI,1.0-1.9)。

结论和相关性

改变小 PTC 的术语可能是降低患者焦虑水平并帮助他们考虑采用侵袭性较小的管理方案的一种策略。为了遏制 PTC 的过度诊断和过度治疗,其他策略可能包括提供关于替代治疗风险和优势的平衡信息。

试验注册

anzctr.org.au 标识符:ACTRN12616000271404。